How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

17,952 results for

Assistive Technology

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Assistive Technology ? Digital tools that involve social stimulation for mental health in later life

Assistive Technology ? Digital tools that involve social stimulation for mental health in later life Assistive Technology – Digital tools that involve social stimulation for mental health in later life We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Assistive Technology – Digital tools that involve social stimulation for mental health in later life (...) Evidence map Share: Reading time approx. 4 minutes Background Assistive technology includes digital tools and information technologies that aim to maintain or increase the security, activity, social participation, or independence of individuals who have or are at risk of developing mental ill health or impairments. Assistive technology overlaps with traditional adaptive technology as it includes compensatory and medical technologies designed to address a specific disability or medical condition

2018 Swedish Council on Technology Assessement

2. Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies. (PubMed)

Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies. In order to overcome the low effectiveness of assisted reproductive technologies (ART) and the high incidence of multiple births, metabolomics is proposed as a non-invasive method to assess oocyte quality, embryo viability, and endometrial receptivity, and facilitate a targeted subfertility treatment.To evaluate the effectiveness and safety of metabolomic assessment of oocyte quality, embryo

2018 Cochrane

3. Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer). (PubMed)

Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer). The female genital tract is not exposed to seminal plasma during standard assisted reproductive technology (ART) cycles. However, it is thought that the inflammatory reaction triggered by seminal plasma may be beneficial by inducing maternal tolerance to paternal antigens expressed by the products of conception, and may increase

2018 Cochrane

4. Assisted reproductive technology: an overview of Cochrane Reviews. (PubMed)

Assisted reproductive technology: an overview of Cochrane Reviews. As many as one in six couples will encounter problems with fertility, defined as failure to achieve a clinical pregnancy after regular intercourse for 12 months. Increasingly, couples are turning to assisted reproductive technology (ART) for help with conceiving and ultimately giving birth to a healthy live baby of their own. Fertility treatments are complex, and each ART cycle consists of several steps. If one of these steps (...) is incorrectly applied, the stakes are high as conception may not occur. With this in mind, it is important that each step of the ART cycle is supported by good evidence from well-designed studies.To summarise the evidence from Cochrane systematic reviews on procedures and treatment options available to couples with subfertility undergoing assisted reproductive technology (ART) procedures.Published Cochrane systematic reviews of couples undergoing ART procedures (in vitro fertilisation or intracytoplasmic

2018 Cochrane

5. Assistive technology for memory support in dementia. (PubMed)

Assistive technology for memory support in dementia. The sustained interest in electronic assistive technology in dementia care has been fuelled by the urgent need to develop useful approaches to help support people with dementia at home. Also the low costs and wide availability of electronic devices make it more feasible to use electronic devices for the benefit of disabled persons. Information Communication Technology (ICT) devices designed to support people with dementia are usually referred (...) to as Assistive Technology (AT) or Electronic Assistive Technology (EAT). By using AT in this review we refer to electronic assistive devices. A range of AT devices has been developed to support people with dementia and their carers to manage their daily activities and to enhance safety, for example electronic pill boxes, picture phones, or mobile tracking devices. Many are commercially available. However, the usefulness and user-friendliness of these devices are often poorly evaluated. Although reviews

Full Text available with Trip Pro

2017 Cochrane

6. Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies. (PubMed)

Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies. In order to overcome the low effectiveness of assisted reproductive technologies (ART) and the high incidence of multiple births, metabolomics is proposed as a non-invasive method to assess oocyte quality, embryo viability, and endometrial receptivity, and facilitate a targeted subfertility treatment.To evaluate the effectiveness and safety of metabolomic assessment of oocyte quality, embryo

2017 Cochrane

7. Enhancing Equitable Access to Assistive Technologies in Canada

Enhancing Equitable Access to Assistive Technologies in Canada EVIDENCE BRIEF ENHANCING EQUITABLE ACCESS TO ASSISTIVE TECHNOLOGIES IN CANADA 8 JUNE 2017 Evidence Brief Enhancing Equitable Access to Assistive Technologies in Canada 20 June 2017 McMaster Health Forum 1 Evidence >> Insight >> Action Evidence Brief: Enhancing Equitable Access to Assistive Technologies in Canada 8 June 2017 McMaster Health Forum 2 Evidence >> Insight >> Action McMaster Health Forum For concerned citizens (...) priority assistive technologies’ coverage by province and territory. We are grateful to the Steering Committee members (Jerome Bickenbach, Amanda Grenier, Jeff Jutai, Don Juzwishin, Sandra MacLeod and Andria Spindel), and merit reviewers (Mark Harasymuk, John Rafferty, Paul Stolee, Chiranjeev Sanyal, Maggie MacNeil and Fay Wambolt) for providing feedback on previous drafts of the brief. The views expressed in the evidence brief should not be taken to represent the views of these individuals. Citation

2017 McMaster Health Forum

8. Assistive technology - digital tools that involve social stimulation for mental health in later life

Assistive technology - digital tools that involve social stimulation for mental health in later life Assistive technology – digital tools that involve social stimulation for mental health in later life Assistive technology – digital tools that involve social stimulation for mental health in later life SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services Record Status This is a bibliographic record of a published health technology assessment from a member (...) of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services. Assistive technology – digital tools that involve social stimulation for mental health in later life. Stockholm: Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU). SBU Evidence Map. 2017 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Humans; Life

2017 Health Technology Assessment (HTA) Database.

9. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. (PubMed)

Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Advances in cell culture media have led to a shift in in vitro fertilisation (IVF) practice from cleavage stage embryo transfer to blastocyst stage transfer. The rationale for blastocyst transfer is to improve both uterine and embryonic synchronicity and enable self selection of viable embryos, thus resulting in better live birth rates.To determine whether blastocyst stage (day 5 to 6) embryo transfers (...) assisted reproductive technology (ART) and service providers to make well informed decisions on the best treatment option available.

Full Text available with Trip Pro

2016 Cochrane

10. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. (PubMed)

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Gonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-oestrogenic side-effects, flare-up, or long down-regulation period associated with agonists. The antagonists directly and rapidly inhibit gonadotrophin release within several hours through competitive binding to pituitary GnRH receptors (...) hyperstimulation in assisted conception cycles.We searched the Cochrane Menstrual Disorders and Subfertility Group Trials Register (searched from inception to May 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, inception to 28 April 2015), Ovid MEDLINE (1966 to 28 April 2015), EMBASE (1980 to 28 April 2015), PsycINFO (1806 to 28 April 2015), CINAHL (to 28 April 2015) and trial registers to 28 April 2015, and handsearched bibliographies of relevant publications

Full Text available with Trip Pro

2016 Cochrane

11. Assisted reproductive technologies for male subfertility. (PubMed)

Assisted reproductive technologies for male subfertility. Intra-uterine insemination (IUI), in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) are frequently used fertility treatments for couples with male subfertility. The use of these treatments has been subject of discussion. Knowledge on the effectiveness of fertility treatments for male subfertility with different grades of severity is limited. Possibly, couples are exposed to unnecessary or ineffective treatments

2016 Cochrane

12. Percutaneous ventricular assist devices: a health technology assessment

Percutaneous ventricular assist devices: a health technology assessment Percutaneous ventricular assist devices: a health technology assessment Percutaneous ventricular assist devices: a health technology assessment Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Percutaneous ventricular (...) assist devices: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario Health Technology Assessment Series; 17(2). 2017 Authors' conclusions On the basis of evidence of low to very low quality, Impella 2.5 devices were associated with improved hemodynamic stability, but had mortality rates and safety profile similar to IABPs in high-risk PCI and cardiogenic shock. Our cost-effectiveness analysis indicated that Impella 2.5 is likely associated with greater costs and fewer

2017 Health Technology Assessment (HTA) Database.

13. International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. (PubMed)

International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. To report the utilization, effectiveness, and safety of practices in assisted reproductive technology (ART) globally in 2011 and assess global trends over time.Retrospective, cross-sectional survey on the utilization, effectiveness, and safety of ART procedures performed globally during 2011.Sixty-five countries and 2,560 ART clinics.Women and men undergoing ART (...) procedures.All ART.The ART cycles and outcomes on country-by-country, regional, and global levels. Aggregate country data were processed and analyzed based on methods developed by the International Committee for Monitoring Assisted Reproductive Technology (ICMART).A total of 1,115,272 ART cycles were reported for the treatment year 2011. Imputing data for nonreporting clinics, 1,643,912 cycles resulted in >394,662 babies, excluding People's Republic of China. The best estimate of global utilization including

2018 Fertility and Sterility

14. National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologies. (PubMed)

National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologies. To assess the attitudes of Society for Assisted Reproductive Technology (SART) members regarding expanding insurance coverage for patients seeking assisted reproductive technologies (ART) and identify some of the factors that may influence such attitudes.An anonymous online 14-question survey of SART membership; 1,556 surveys were sent through

2018 Fertility and Sterility

15. Left ventricular assist devices for destination therapy: a health technology assessment

Left ventricular assist devices for destination therapy: a health technology assessment Left ventricular assist devices for destination therapy: a health technology assessment Left ventricular assist devices for destination therapy: a health technology assessment Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) Health Quality Ontario. Left ventricular assist devices for destination therapy: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario Health Technology Assessment Series; 16(3). 2016 Authors' conclusions For patients with end-stage heart failure who are ineligible for heart transplantation, permanent treatment with continuous-flow LVADs is effective at improving survival and quality of life compared with drug therapy. However, permanent continuous-flow devices have higher

2016 Health Technology Assessment (HTA) Database.

16. Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology. (PubMed)

Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology. To examine outcomes of singleton pregnancies conceived without assisted reproductive technology (non-ART) compared with singletons conceived with ART by elective single-embryo transfer (eSET), nonelective single-embryo transfer (non-eSET), and double-embryo transfer with the establishment of 1 (DET -1) or ≥2 (DET ≥2) early fetal

2017 Fertility and Sterility

17. Correct coding for laboratory procedures during assisted reproductive technology cycles: a committee opinion

Correct coding for laboratory procedures during assisted reproductive technology cycles: a committee opinion Correct coding for laboratory procedures during assisted reproductive technology cycles Coding Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama This document provides updated coding information for services related to assisted repro- ductive technology procedures. This document replaces the 2012 ASRM document (...) or was cryopreserved. A single code quickly became inadequate to describe the many different components of work involved as the variety and complexity of assisted reproductive technology (ART) expanded. As tech- nology has changed, new CPT codes have been added to describe the work performed in the ART setting. This document outlines the proper use of individual and speci?c codes for each component of the laboratory work involved in an IVF cycle. Bundling of multiple procedures into one or two codes is no longer

2016 Society for Assisted Reproductive Technology

18. Perinatal Risks Associated With Assisted Reproductive Technology

Perinatal Risks Associated With Assisted Reproductive Technology Perinatal Risks Associated With Assisted Reproductive Technology - ACOG Menu ▼ Perinatal Risks Associated With Assisted Reproductive Technology Page Navigation ▼ Number 671, September 2016 (Replaces Committee Opinion No. 324, November 2005) (Reaffirmed 2018) Committee on Obstetric Practice Committee on Genetics The American Society for Reproductive Medicine and the Society for Maternal–Fetal Medicine endorse this document (...) as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Perinatal Risks Associated With Assisted Reproductive Technology ABSTRACT: Over the past decades, the use of assisted reproductive technology (ART) has increased dramatically worldwide and has made pregnancy possible for many infertile couples. Although the perinatal risks that may be associated with ART and ovulation induction are much higher

2016 American College of Obstetricians and Gynecologists

19. Improving access to assistive technology: Report by the Secretariat

Improving access to assistive technology: Report by the Secretariat Improving access to assistive technology: report by the Secretariat JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Improving access to assistive technology: report by the Secretariat View/ Open View Statistics Altmetrics Share Citation Executive Board, 139 . (‎2016)‎. Improving access to assistive technology

2016 WHO

20. An Assistive Technology System that Provides Personalized Dressing Support for People Living with Dementia: Capability Study (PubMed)

An Assistive Technology System that Provides Personalized Dressing Support for People Living with Dementia: Capability Study Individuals living with advancing stages of dementia (persons with dementia, PWDs) or other cognitive disorders do not have the luxury of remembering how to perform basic day-to-day activities, which in turn makes them increasingly dependent on the assistance of caregivers. Dressing is one of the most common and stressful activities provided by caregivers because of its (...) complexity and privacy challenges posed during the process.In preparation for in-home trials with PWDs, the aim of this study was to develop and evaluate a prototype intelligent system, the DRESS prototype, to assess its ability to provide automated assistance with dressing that can afford independence and privacy to individual PWDs and potentially provide additional freedom to their caregivers (family members and professionals).This laboratory study evaluated the DRESS prototype's capacity to detect

Full Text available with Trip Pro

2018 JMIR medical informatics

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>